Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid versus percutaneous thermal ablation for osteoid osteoma
2015-001698-41Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of zoledronic acid in Osteoid osteoma (OO) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Primary: treatment success at end of treatment. Started Mar 2016; status: completed.
02
Drugs
zoledronic acid
03
Conditions
Osteoid osteoma (OO)
Beyond the preview
Go deeper on 2015-001698-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001698-41.